We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
93
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Roper Technologies
ROP
$38.8B
| $84.9M | 0.12% |
190,389
-16,753
| -8% | -$8.03M |
|
|
XYZ
152
Block Inc
XYZ
$48.9B
| $84.4M | 0.11% |
352,069
-20,336
| -5% | -$5.22M |
|
153
Illumina
ILMN
$29.9B
| $83.8M | 0.11% |
212,467
-3,933
| -2% | -$1.81M |
|
154
Chipotle Mexican Grill
CMG
$47.4B
| $82.9M | 0.11% |
2,281,500
+22,950
| +1% | +$835K |
|
155
Align Technology
ALGN
$12.4B
| $82.5M | 0.11% |
124,019
+1,756
| +1% | +$1.19M |
|
156
HCA Healthcare
HCA
$88B
| $82M | 0.11% |
337,842
-21,033
| -6% | -$5.14M |
|
157
eBay
EBAY
$47.6B
| $81.9M | 0.11% |
1,174,836
-43,797
| -4% | -$3.14M |
|
158
T. Rowe Price
TROW
$24.2B
| $81.1M | 0.11% |
412,309
-24,971
| -6% | -$5.26M |
|
159
American International
AIG
$41.8B
| $80.3M | 0.11% |
1,462,107
-43,815
| -3% | -$2.26M |
|
160
Johnson Controls International
JCI
$88.7B
| $80.2M | 0.11% |
1,178,292
-15,027
| -1% | -$1.09M |
|
161
KLA
KLAC
$239B
| $80.2M | 0.11% |
2,396,150
-49,710
| -2% | -$1.66M |
|
162
Exelon
EXC
$47B
| $78.7M | 0.11% |
2,281,857
-57,156
| -2% | -$1.95M |
|
|
BNY
163
Bank of New York Mellon
BNY
$106B
| $78.2M | 0.11% |
1,509,116
+73,910
| +5% | +$3.84M |
|
164
MSCI
MSCI
$41.8B
| $78.1M | 0.11% |
128,375
+192
| +0.1% | +$117K |
|
165
NXP Semiconductors
NXPI
$56.5B
| $77.3M | 0.1% |
394,435
-20,801
| -5% | -$4.32M |
|
166
Freeport-McMoran
FCX
$91.5B
| $76.8M | 0.1% |
2,360,405
-8,954
| -0.4% | -$315K |
|
167
Dow Inc
DOW
$21.6B
| $76.5M | 0.1% |
1,329,461
+31,943
| +2% | +$1.96M |
|
168
ResMed
RMD
$31.2B
| $76.5M | 0.1% |
290,339
-11,482
| -4% | -$3.14M |
|
169
Agilent Technologies
A
$39.5B
| $76.4M | 0.1% |
484,823
+2,928
| +0.6% | +$474K |
|
170
Biogen
BIIB
$29.8B
| $76.2M | 0.1% |
269,433
-4,906
| -2% | -$1.61M |
|
171
Mettler-Toledo International
MTD
$29B
| $76.2M | 0.1% |
55,349
+3,056
| +6% | +$4.6M |
|
172
MetLife
MET
$62B
| $76.1M | 0.1% |
1,232,295
-48,062
| -4% | -$2.89M |
|
173
Paychex
PAYX
$41.9B
| $74.9M | 0.1% |
666,239
-8,664
| -1% | -$973K |
|
174
O'Reilly Automotive
ORLY
$73.3B
| $73.4M | 0.1% |
1,802,925
-41,745
| -2% | -$1.67M |
|
175
Synopsys
SNPS
$75.1B
| $72.9M | 0.1% |
243,595
+741
| +0.3% | +$225K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 93 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 93 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.